Objective: Recent studies have demonstrated that statins have pleiotropic effects, including anti-inflammatory effects and atrial fibrillation (AF) preventive effects. The objective of this study was to assess the efficacy of preoperative statin therapy in preventing AF after coronary artery bypass grafting (CABG). Methods: 221 patients underwent CABG in our hospital from 2004 to 2007. 14 patients with preoperative AF and 4 patients with concomitant valve surgery were excluded from this study. Patients were divided into two groups to examine the influence of statins: those with preoperative statin therapy (Statin group, n = 77) and those without it (Non-statin group, n = 126). In addition, patients were divided into two groups to determine the independent predictors for postoperative AF: those with postoperative AF (AF group, n = 54) and those without it (Non-AF group, n = 149). Patient data were collected and analyzed retrospectively. 
Introduction
Atrial fibrillation (AF) is one of the most common complications after coronary artery bypass grafting (CABG) and it occurs in 20% to 40% of patients after CABG. [1] [2] [3] Postoperative AF is likely to be troublesome because it usually occurs within a few days after surgery with unstable hemodynamics.
The relationship between ischemic heart disease and hyperlipidemia is well known, and therefore many patients with ischemic heart disease are treated concurrently for hyperlipidemia. The major drugs for the treatment of hyperlipidemia are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, known as statins.
Recent studies have demonstrated that statins have pleiotropic effects. Reported effects include: decreased levels of high-sensitivity C-reactive protein (CRP), decreased plaque area in coronary arteries, reduced number of cardiac events after CABG, myocardial protective effects after ischemic reperfusion injury, AF preventive effects after CABG and others. [4] [5] [6] [7] [8] The objective of this study was to assess the efficacy of preoperative statin therapy in preventing AF after CABG. Also, the time-dependent change of CRP levels was analyzed to assess the relationship between inflammation and statins.
Patients and Methods

Patient population
Patient data were collected and analyzed retrospectively. This retrospective study was approved by the ethics committee of Hitachi General Hospital. Our committee waived the need for obtaining informed consent from each patient for this retrospective study.
From January 2004 to December 2007, 221 patients underwent CABG at Hitachi General Hospital. Fourteen patients with preoperative AF and 4 patients with concomitant valve surgery were excluded from this study. Thus, 203 patients who underwent isolated CABG were included in the study population.
Patients were divided into two groups to examine the influence of statins: those with preoperative statin therapy (Statin group, n = 77) and those without it (Non-statin group, n = 126). In addition, patients were divided into two groups to determine the independent predictors for postoperative AF: those with postoperative AF (AF group, n = 54) and those without it (Non-AF group, n = 149).
The Statin group had been administered one of the following statins for hyperlipidemia by their cardiologist before being admitted to our department: atorvastatin, pravastatin, pitavastatin, rosuvastatin, simvastatin, or fluvastatin. The type, dose, or duration of preoperative statin therapy was not uniform, because this is a retrospective study. Preoperative statins were omitted on the day of the operation and re-started from the average of 1.47 days after the operation in the Statin group. Other routine postoperative medications were aspirin, ticlopidine hydrochloride, isosorbide mononitrate, diltiazem hydrochloride, and famotidine in our hospital.
All surgeries were performed through a median sternotomy using either an on-pump or off-pump technique. Cardiopulmonary bypass (CPB) was conducted using ascending aortic cannulation and bicaval cannulation, mild hypothermia (32°C), and cold blood cardioplegic arrest. Off-pump CABG (OPCAB) was performed using a heart stabilizer.
Data collection
All patients were monitored daily with continuous electrocardiographic telemetry for a minimum of 11 days after the operation. AF was defined as episodes lasting for longer than 5 minutes, as documented by telemetry.
The presence of AF was determined from clinical records.
Statistical methods
Continuous variables are presented as mean ± standard deviation and were compared between groups using a t-test. Categorical data are presented as percentages and were compared between groups using the chi-square test. First, univariate analysis was performed to examine the relationship between variables and statin therapy, and the relationship between variables and the development of postoperative AF. Then, preoperative and perioperative variables which showed univariate relation (p < 0.25) with postoperative AF occurrence or which were previously demonstrated to be strong, independent predictors of AF 1-3, 9, 10) were entered into a multivariate logistic regression analysis model to determine the independent predictors for postoperative AF. The time-dependent change of CRP levels was analyzed using repeated measures ANOVA. All analyses were performed using the SPSS statistical software version 17.0 for Windows (SPSS Inc., Chicago, IL, USA). A p value of less than 0.05 was considered statistically significant.
Results
The results of the univariate analysis of pre-, peri-, and postoperative variables between the Statin group and the Non-statin group are shown in Tables 1, 2 , and 3. Similarly, these tables show the results of univariate analysis between the AF group and the Non-AF group.
The Statin group was significantly younger compared to the Non-statin group (p = 0.007). The AF group was significantly older (p = 0.001). Regarding preoperative oral medicine, calcium blockers, angiotensin II type I receptor blockers, and beta-blockers did not appear to influence the development of postoperative AF. The usage rate of beta-blockers between the AF group and the Non-AF group was similar (24% versus 33%, p = 0.228) ( Table 1) .
As for perioperative factors, there were no significant differences between groups except for preoperative intraaortic balloon pumping (IABP) usage. Preoperative IABP usage rate was significantly lower in the Statin group compared with the Non-statin group ( Table 2) .
Regarding postoperative factors, there were no significant differences between groups in postoperative ventilation time, ICU stay, and incidence of complications. Moreover, thirty-day mortality was almost the same. The overall incidence of postoperative AF was 26%. Postoperative AF occurred in 12 patients (16%) in the Statin group. This was significantly lower compared with 42 patients (33%) in the Non-statin group (p = 0.005). The time between surgery and AF development was significantly longer in the Statin group compared with the Non-statin group (4.4 ± 3.4 days versus 2.6 ± 1.8 days, p = 0.024) ( Table 3) .
According to multivariate analysis, the following variables were entered into a multivariate logistic regression analysis model: age, unstable angina, hypertension, hyperlipidemia, diabetes mellitus, renal failure, cerebrovascular disease, cardiothoracic ratio, statins, beta-blockers, triglyceride, emergent operation, intra-aortic balloon pumping, OPCAB, male sex, chronic obstructive lung disease, and ejection fraction. Preoperative statin therapy demonstrated a significant inverse relation with postoperative AF development (odds ratio [OR] 0.327, 95% confidence interval [CI] 0.107 to 0.998, p = 0.05). Also, age was an independent predictor of postoperative AF (OR 1.058, 95% CI 1.004 to 1.116, p = 0.035). Emergent operation was excluded from the analysis process by the SPSS software. The detail results are shown in Table 4 .
As for the relation with inflammation, repeated measures ANOVA indicated that the time-dependent change of CRP levels had no significant differences between the Statin and the Non-statin groups, nor between the AF and the Non-AF groups. However, a t-test indicated that CRP levels on postoperative days 7 and 14 were significantly lower in the Statin group compared with the Non-statin Table 5) . Table 6 shows the type of statins and the incidence of AF. Postoperative AF occurred in patients with atorvastatin, pravastatin, or pitavastatin. However, no relationship was found between the type of statins and postoperative AF, because the frequency of use of each statin was significantly different.
Discussion
Statin therapy is actively performed on many heart disease patients. Many previous studies revealed that statins had the following pleiotropic effects: anti-inflammatory effects; cardiac event preventive effects; coronary plaque regression effects; and others. [4] [5] [6] [7] [8] Moreover, recent studies revealed that statins had preventive effects on postoperative AF. [11] [12] [13] For example, ARMYDA-3 is the first randomized, controlled trial to evaluate the impact of preoperative statin therapy on postoperative AF. 11) In ARMYDA-3, 200 patients were randomized to either preoperative atorvastatin (40 mg/day) or placebo starting 7 days before heart surgery. As a result, preoperative atorvastatin reduced the risk of postoperative AF by 61%, with an incidence of 35% in the atorvastatin group versus 57% in the placebo group. Previous studies also revealed that beta-blocker, amiodarone, and sotalol had preventive effects on postoperative AF. 14, 15) However, these drugs have potential cardiovascular side effects, such as hypotension, bradycardia, atrioventricular block, Torsades de pointes, and others. If the preventive effects of statins on postoperative AF can be confirmed, statins would become a very useful medicine because they do not aggravate hemodynamics.
In our study, univariate and multivariate analysis revealed that preoperative statin therapy had a significant preventive effect on AF development after CABG. Moreover, even if AF occurred after CABG, preoperative statin therapy delayed the onset of the first postoperative AF. In the Statin group, AF occurrence after CABG was approximately 2 days later than in the Non-statin group. This fact is meaningful for postoperative care, as it indicates that preoperative statin therapy can avoid AF development in unstable hemodynamics immediately after surgery.
Previously, many studies of postoperative AF have been done and described that predictors of postoperative AF were advanced age, male sex, and others. [1] [2] [3] Similarly, multivariate analysis showed age was a preoperative independent predictor of postoperative AF in our study. Amiodarone and sotalol, which had a prophylactic effect on AF, were not administered to our patients in the pre-and perioperative periods. Previous studies also revealed that beta-blockers had AF preventive effects. 14, 15) In our study, 62 patients had been administered betablockers preoperatively, but there was no significant difference in preoperative beta-blocker usage between the AF and the Non-AF groups. We considered the reason was that beta-blockers were not restarted after CABG in our patients. In fact, a previous multicenter study suggested that postoperative withdrawal of beta-blockers increased the risk of AF development after CABG.
3) Some previous reports described that patients who underwent OPCAB had lower rates of postoperative AF compared with conventional CABG. 16, 17) In contrast, other reports revealed there was no significant difference in the incidence of postoperative AF between OPCAB and conventional CABG. 12, 18) Similarly, ratio of OPCAB was 39% in the AF group versus 42% in the Non-AF group in our study. There was no significant difference. We consider that it is still controversial whether OPCAB is identified as a protective factor of postoperative AF.
Regarding the anti-inflammatory effects of statins, it has been reported that statins have the effect of reducing high-sensitivity CRP levels. 4, 5, 19) Nissen and colleagues reported that atorvastatin therapy for 18 months reduced high-sensitivity CRP levels by 36% from baseline. 4) In our study, repeated measures ANOVA revealed that the time-dependent change of CRP levels was not significantly different between the Statin and the Non-statin groups. A t-test indicated that preoperative CRP levels was not significantly different between the Statin and the Non-statin groups, but CRP levels on postoperative days 7 and 14 were significantly lower in the Statin group compared with the Non-statin group. The reason our two groups had no significant difference in preoperative CRP levels is considered to be because the dose or period of preoperative statin therapy was insufficient. In previous studies from United States and Europe, statins were administered at much higher doses than our usual dose, and were administered for more than 12 months. 4, 5, 19) Also, we considered that CRP levels immediately after CABG were almost the same between the two groups because of the effects of operative stress. And, preoperative statin therapy had potentially decreased CRP levels earlier in the Statin group compared with the Non-statin group.
The REVERSAL trial reported that intensive statin therapy (80 mg of atorvastatin orally per day) reduced progression of coronary atherosclerosis, LDL cholesterol levels, and CRP levels compared with moderate statin therapy (40 mg of pravastatin orally per day). 4, 5) Lertsburapa and colleagues reported that intensive atorvastatin therapy (more than 40 mg orally per day) resulted in the greatest reduction in postoperative AF (55% reduction) compared with moderate therapy (more than 20 mg but less than 40 mg, 43% reduction) or mild therapy (less than 20 mg, 25% reduction). 13) We therefore postulated that postoperative AF correlated with LDL cholesterol levels. As for the LDL lowering therapy by statins for prevention of cardiovascular events, "the lower, the better" is recommended. However, our study revealed that no relationship existed between the LDL levels and postoperative AF. In other words, postoperative AF is not prevented by lowering LDL. This issue must be reviewed in more detail in the future.
There are some limitations to our study. First, it is based on a retrospective analysis of our single center database and a small sample study. Second, the type, dose, or period of preoperative statins was not uniform among our patients. However, the Statin group did not have emergent cases, patients who underwent elective surgery had been admitted to our department at least 5 days before surgery. This means that the preoperative statins had been administered for at least 5 days before surgery. We did not describe in detail the data regarding the statin dosages. In our study the most frequently used was atorvastatin, which was administered at 10 mg to most patients, to a maximum of 20 mg. Other statin dosages administered were equal to or less than the equivalent of 20 mg of atorvastatin. This dose is classified as low dose in previous reports from United States and Europe. If we increase the statin dosages, the effects on preventing AF or decreasing CRP levels may become more remarkable than the current results. Finally, the present study lacked the following information: unreported or undiagnosed episodes of postoperative AF; postoperative variables such as volume overload, dose of inotropic agents, or electrolyte imbalance. We should accumulate more data and conduct further detailed research in the future.
Conclusion
In conclusion, preoperative low dose statin therapy seems to reduce AF development after CABG in our study. It seems useful that statins are routinely administered to patients undergoing elective CABG.
